Partner Headlines - BAYRY

United Therapeutics' Lung Drug Breathes Again

Investors Business Daily
Regeneron, Alexion Big-Cap Biotechs Sales Seen Rising

Investors Business Daily
Allergan Reports Mixed Q4, But Bullish Margin Outlook

Investors Business Daily
Phase 3 DECISION Trial of Nexavar Meets Primary Endpoint

Benzinga
Bristol-Myers, Pfizer drug OK'd

Investors Business Daily
Bristol-Myers, Pfizer Stocks Rise On Eliquis Approval

Investors Business Daily
Hemophilia Treatment Could Take A New Leap

Investors Business Daily
Regeneron's EYLEA Submitted for EU Marketing ...

Benzinga
Benzinga's M&A Chatter for Friday November 16, 2012

Benzinga
Benzinga's M&A Chatter for Tuesday October 30, 2012

Benzinga
Bayer to Acquire Schiff Nutrition $1.2B

Benzinga
Realogy, Shutterstock IPOs, More New Stocks Take Off

Investors Business Daily
Realogy, Shutterstock IPOs, More New Stocks Take Off

Investors Business Daily
Germany ETF Thrives Despite PIIGS For Neighbors

Investors Business Daily
Bayer Posts Decline In Q2 Profit, Lifts Forecast

Benzinga
Bayer CropScience To Acquire AgraQuest

Benzinga
Roche To Sell Blockbuster Cancer Drugs Cheap In India

at IBD
Pfizer

at IBD
Spectrum Pharma's Q4 Hit By Costs, But Stock Rebounds

at IBD
Spectrum Pharma Set To Report First Year Of Profit

at IBD
Regeneron Nearly Doubles Forecast On Eye Drug Sales

at IBD

Marketplace

Trading Center

Partner Links